Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Safety, Pharmacodynamic, and Pharmacokinetic Study of Intravenously Administered PXD101 Plus Carboplatin or Paclitaxel or Both in Patients With Advanced Solid Tumours

NCT00421889 is registered in ClinicalTrials.gov with Valerio Therapeutics as lead sponsor.

NCT NCT00421889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00421889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Safety, Pharmacodynamic, and Pharmacokinetic Study of Intravenously Administered PXD101 Plus Carboplatin or Paclitaxel or Both in Patients With Advanced Solid Tumours
Lead sponsor
Valerio Therapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2005
Completion date
February 28, 2009
Enrollment
80 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, epithelial ovarian cancer, fallopian tube cancer, ovarian cancer